- Home
- Software Solutions
- Resources
- Corporate
A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
Sponsors:
| Phases:
| |
| Indications | Acronym: | |
| ||
Age Groups:
| Gender: Female | |
Names:
| Enrollment: 59 | |
Additional information about NCT00476827.